Research Article
Clinical and Autoimmune Profile of Scleroderma Patients from Western India
Table 2
Distribution of autoantibodies in subgroups of scleroderma patients (
).
| Autoantibodies (%) | Diffused () | Limited () | Overlap () |
| ANA 94 (85.5%) | 39 (86.7%) | 28 (87.5%) | 27 (81.8%) | Anti-Scl70 antibodies 69 (62.7%) | 34* (75.6%) | 15 (46.9%) | 20 (60.6%) | Anti-centromere antibodies 25 (22.7%) | 04** (9%) | 12 (38%) | 09 (27%) | AECA 33 (30%) | 09 (20%) | 15 (48%) | 09 (27%) | AKA 45 (40.9%) | 18 (40%) | 10 (31%) | 17 (51%) |
|
|
, OR = 3.5030, and 95% CI = 1.3256–9.2570. , OR = 0.1626, and 95% CI = 0.0465–0.5684.
|